Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach

Por Lipkovich, Ilya A, Houston, John P, Ahl, Jonna
Publicado em 2008

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder

Por Hardy Thomas A, Jacobson Jennie G, Lipkovich Ilya, Hoffmann Vicki
Publicado em 2008-09-01

Who will benefit from antidepressants in the acute treatment of bipolar depression? A reanalysis of the STEP-BD study by Sachs et al. 2007, using Q-learning

Por Wu, Fan, Laber, Eric B, Lipkovich, Ilya A, Severus, Emanuel
Publicado no Int J Bipolar Disord (2015)

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder

Por Lipkovich, Ilya, Jacobson, Jennie G, Hardy, Thomas A, Hoffmann, Vicki Poole
Publicado em 2008

A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease

Por Liu-Seifert, Hong, Andersen, Scott W., Lipkovich, Ilya, Holdridge, Karen C., Siemers, Eric
Publicado no PLoS One (2015)

Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients

Por Lipkovich, Ilya A, Choy, Ernest H, Van Wambeke, Peter, Deberdt, Walter, Sagman, Doron
Publicado no BMC Musculoskelet Disord (2014)

Identifying Optimal Dosage Regimes Under Safety Constraints: An Application to Long Term Opioid Treatment of Chronic Pain

Por Laber, Eric B., Wu, Fan, Munera, Catherine, Lipkovich, Ilya, Colucci, Salvatore, Ripa, Steve
Publicado no Stat Med (2018)

Evaluating dose response from flexible dose clinical trials

Por Lipkovich, Ilya, Adams, David H, Mallinckrodt, Craig, Faries, Doug, Baron, David, Houston, John P
Publicado em 2008

Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsy...

Por Lipkovich, Ilya A, Deberdt, Walter, Csernansky, John G, Sabbe, Bernard, Keefe, Richard SE, Kollack-Walker, Sara
Publicado em 2009

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

Por Heinloth Alexandra N, Hoffmann Vicki, Lipkovich Ilya, Stauffer Virginia L, McGregor H Scott, Kinon Bruce J
Publicado em 2009-03-01

Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

Por Stauffer, Virginia L, Lipkovich, Ilya, Hoffmann, Vicki Poole, Heinloth, Alexandra N, McGregor, H Scott, Kinon, Bruce J
Publicado em 2009

Understanding Heterogeneity in Response to Antidiabetes Treatment: A Post Hoc Analysis Using SIDES, a Subgroup Identification Algorithm

Por Hardin, Dana S., Rohwer, Rachelle D., Curtis, Bradley H., Zagar, Anthony, Chen, Lei, Boye, Kristina S., Jiang, Honghua H., Lipkovich, Ilya A.
Publicado em 2013

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaff...

Por Deberdt, Walter, Lipkovich, Ilya, Heinloth, Alexandra N, Liu, Lin, Kollack-Walker, Sara, Edwards, Sara E, Hoffmann, Vicki Poole, Hardy, Thomas A
Publicado em 2008

Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years

Por Liu-Seifert, Hong, Siemers, Eric, Holdridge, Karen C., Andersen, Scott W., Lipkovich, Ilya, Carlson, Christopher, Sethuraman, Gopalan, Hoog, Sharon, Hayduk, Roza, Doody, Rachelle, Aisen, Paul
Publicado no Alzheimers Dement (N Y) (2015)